Fibroblast Growth Factor Research
Fibroblast Growth Factor Research is a research topic within Molecular Biology. Science Explorer counts 17k research works in it since 1950. 18.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the Fibroblast Growth Factor (FGF) signaling pathway, covering its role in development, metabolism, cancer, and therapy. It explores the involvement of FGF21, FGF receptors, and PPARa in various physiological processes such as hepatic lipid metabolism, insulin sensitivity, and bone development. Additionally, it discusses the potential therapeutic implications of targeting FGF signaling in conditions like obesity and cancer.
- Fibroblast Growth Factor
- FGF21
- Receptor
- Signaling
- Cancer
- Metabolism
- Therapy
- Development
- PPARa
- Obesity
- Research works
- 17k fractional, since 1950
- In the world top 10%
- 3.3k per year above
- Top-10% rate
- 18.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +6% the tick is no change
Which countries lead Fibroblast Growth Factor Research research?
By volume, China and the United States publish the most (783 and 555 works in 2022–2025).
By volume, 2022–2025
- 1 China 783 works
- 2 United States 555 works
- 3 Japan 164 works
- 4 Germany 91 works
- 5 Italy 73 works
- 6 India 70 works
- 7 South Korea 68 works
- 8 France 62 works
- 9 United Kingdom 60 works
- 10 Spain 51 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Fibroblast Growth Factor Research research?
By volume in 2022–2025, Wenzhou Medical University publishes the most Fibroblast Growth Factor Research research, followed by Sichuan University and Sun Yat-sen University.
By volume, 2022–2025
- 1 Wenzhou Medical UniversityChina 28 works
- 2 Sichuan UniversityChina 12 works
- 3 Sun Yat-sen UniversityChina 12 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 11 works
- 5 The University of Texas MD Anderson Cancer CenterUnited States 10 works
- 6 Shanghai Jiao Tong UniversityChina 10 works
- 7 First Affiliated Hospital of Wenzhou Medical UniversityChina 9 works
- 8 Massachusetts General HospitalUnited States 9 works
- 9 University of Arkansas at FayettevilleUnited States 9 works
- 10 InsermFrance 9 works
Who are the leading researchers in Fibroblast Growth Factor Research?
The most-cited researchers publishing on Fibroblast Growth Factor Research include Matthew Meyerson and Yi Zhang.
- 1 Matthew Meyerson United States 4.2k citations
- 2 Yi Zhang China 3.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Fibroblast Growth Factor Research research done?
The largest centres of Fibroblast Growth Factor Research research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Wenzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Wenzhou.
Largest cities, 2022–2025
Where it is the local speciality
- WenzhouCN · 45.7 works22×
Location quotient: how much more of its research is in Fibroblast Growth Factor Research than the world average.
Where is the best place to study Fibroblast Growth Factor Research?
Among universities, judged by research, Wenzhou Medical University, Sichuan University and Nanjing Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Wenzhou Medical UniversityChina | 70.7 | 26.6% | 33.2× | 28 | +42.1% |
| 2 | Sichuan UniversityChina | 42.5 | 36.0% | 2.9× | 12 | +7.3% |
| 3 | Nanjing Medical UniversityChina | 35.9 | 21.4% | 7.2× | 9 | +25.3% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 32.5 | 23.8% | 4.6× | 11 | -15.6% |
| 5 | Sun Yat-sen UniversityChina | 30.7 | 20.6% | 3.1× | 12 | +44.7% |
| 6 | University of Arkansas at FayettevilleUnited States | 27.7 | 7.3% | 16.2× | 9 | -60.4% |
| 7 | Shanghai Jiao Tong UniversityChina | 27.2 | 21.2% | 1.9× | 10 | +86.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Fibroblast Growth Factor Research research growing?
Output in 2018–2022 was 6% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Fibroblast Growth Factor Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.